FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

36037811000001100: Lanreotide 30mg powder and solvent for suspension for injection vials (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 28-Nov 2018. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
111056801000001114 Lanreotide 30mg powder and solvent for suspension for injection vials (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
111056901000001115 Lanreotide 30mg powder and solvent for suspension for injection vials en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

1 descendants. Search Descendants:

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Lanreotide 30mg powder and solvent for suspension for injection vials VMP non-availability indicator Not available true Inferred relationship Existential restriction modifier
Lanreotide 30mg powder and solvent for suspension for injection vials Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Lanreotide 30mg powder and solvent for suspension for injection vials Has NHS dm+d (dictionary of medicines and devices) dose form indicator Discrete dose form indicator true Inferred relationship Existential restriction modifier
Lanreotide 30mg powder and solvent for suspension for injection vials Has NHS dm+d (dictionary of medicines and devices) VMP (Virtual Medicinal Product) ontology form and route suspensioninjection.intramuscular ontology form and route true Inferred relationship Existential restriction modifier
Lanreotide 30mg powder and solvent for suspension for injection vials Has NHS dm+d (dictionary of medicines and devices) VMP (Virtual Medicinal Product) route of administration Intramuscular route true Inferred relationship Existential restriction modifier
Lanreotide 30mg powder and solvent for suspension for injection vials Is a Lanreotide true Inferred relationship Existential restriction modifier
Lanreotide 30mg powder and solvent for suspension for injection vials Is a Product containing lanreotide false Inferred relationship Existential restriction modifier
Lanreotide 30mg powder and solvent for suspension for injection vials Has active ingredient Lanreotide false Inferred relationship Existential restriction modifier
Lanreotide 30mg powder and solvent for suspension for injection vials Has dispensed dose form Powder and solvent for suspension for injection true Inferred relationship Existential restriction modifier
Lanreotide 30mg powder and solvent for suspension for injection vials Has specific active ingredient Lanreotide acetate true Inferred relationship Existential restriction modifier
Lanreotide 30mg powder and solvent for suspension for injection vials VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Lanreotide 30mg powder and solvent for suspension for injection vials VMP non-availability indicator Available false Inferred relationship Existential restriction modifier
Lanreotide 30mg powder and solvent for suspension for injection vials Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Lanreotide true Inferred relationship Existential restriction modifier
Lanreotide 30mg powder and solvent for suspension for injection vials Is a Virtual medicinal product true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Lanreotide 30mg powder and solvent for suspension for injection vials 1 vial Has VMP True Lanreotide 30mg powder and solvent for suspension for injection vials Inferred relationship Existential restriction modifier
Somatuline LA 30mg powder and solvent for suspension for injection vials (Ipsen Ltd) Is a True Lanreotide 30mg powder and solvent for suspension for injection vials Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start